In scramble shRNA MDS mice, the tumor weight showed a trend to decrease, but did not reach a significant change in the Ara-C treatment group (1.91 g vs . 1.53 g with PBS vs .
← all excerpts
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes.
1
—
—